In China, its infant formula market share value rose from 5.4% to 6%, while in Australia and New Zealand that product's value share rose from 35.7% to 36.8%.
China distribution outlets rose by 1350 to a total 13,600, while US liquid milk distributors rose by 300 to 12,700 for the period, a2 Milk said in a NZX investor presentation yesterday.
''Infant formula, liquid milk and other nutritional product performance remains strong,'' Mr Foster said.
Group revenue accelerated a little in its third quarter, with sales for the nine months through March 31 being up 42%.
However, it said second-half sales should be broadly in line with the first as it pumps money into marketing and building organisational capacity.
Group revenue was $938million, reflecting continued sales growth in nutritional products and liquid milk, the company said.
The company's shares eased 2.3% to trade around $16.37 yesterday, but were up almost 40% on a year ago.
In New Zealand and Australia, its market share for a2 branded fresh milk was around 11% as of March 24, up from 10.8% in December, according to rolling 12-month data from the Aztec Australian Grocery Weighted Scan. Its a2 Platinum infant formula value market share lifted to 36.8% from 35.75% in the same period.
a2 Milk said the Kantar market tracking of large Chinese cities showed its infant formula consumption value share increased to 6% as of March, up from 5.4% in December.
While a2 Milk is expecting second-half group revenue growth to be broadly in line with the first, it reiterated its second-half earnings before interest, tax, depreciation and amortisation (ebitda) margins will be lower.
Full-year ebitda as a percentage of sales will be 31% to 32% due to marketing investment, investment in organisational capability and the weaker Australian dollar versus the New Zealand dollar.
Revenue lifted 41% on the year in the first-half to $613.1million, while ebitda was up 53% at $218.4million.
